Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives $65.00 Average Target Price from Analysts
Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have earned a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, Marketbeat reports. Six analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year […]
Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have earned a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, Marketbeat reports. Six analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year […]
